Trials / Completed
CompletedNCT06428253
Efficacy and Safety of HMM1-022 in Temporary Correction of Crow's Feet
A Single Center, Subject & Evaluator-blind, Randomized, Matched Pairs, Active-controlled, Confirmatory Study to Evaluate the Efficacy and Safety of HMM1-022 in Temporary Correction of Crow's Feet
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 171 (actual)
- Sponsor
- Humedix Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy and safety of HMM1-022 with Rejuran to improve Crow's feet
Detailed description
A single center, subject \& evaluator-blind, randomized, matched pairs, active-controlled, confirmatory study to evaluate the efficacy and safety of HMM1-022 in temporary correction of Crow's feet
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HMM1-022 | intradermal injection |
Timeline
- Start date
- 2024-05-14
- Primary completion
- 2025-11-27
- Completion
- 2025-11-27
- First posted
- 2024-05-24
- Last updated
- 2025-12-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06428253. Inclusion in this directory is not an endorsement.